P95 CV has acquired 100% of the shares in Pallas health research & consultancy B.V. (Pallas). IRIS CF acted as sell-side advisor for Pallas during this transaction.
Pallas, located in Rotterdam, is a research and consultancy firm specialized in the fields of biomedical science, epidemiology, public health, and health care. The services of Pallas encompass systematic literature review, study design (e.g. health surveys), statistical data analysis, scientific writing, qualitative research and project management.
For more information, please visit: https://www.pallas-healthresearch.com/
P95 is a Leuven-based company specialized in epidemiology and pharmacovigilance. In 2021, P95 has become an important player on the international stage of vaccine development, working for almost all major vaccine producers and international institutions such as the World Health Organization, the Gates Foundation and the European Commission. With a team of epidemiologists, statisticians, medical writers and analysts, P95 conducts epidemiological studies to help clients plan the development of new vaccines and monitor the effects of vaccines on the market. P95 also contributes to the development of COVID-19 vaccines and follow-up of their effectiveness after approval.
For more information, please visit: https://www.p-95.com/